Literature DB >> 16648334

A 12-month follow-up study of the course of body dysmorphic disorder.

Katharine A Phillips1, Maria E Pagano, William Menard, Robert L Stout.   

Abstract

OBJECTIVE: This study investigated the course of body dysmorphic disorder (BDD), a relatively common and severe disorder, in the first prospective follow-up study, to the authors' knowledge.
METHOD: In this study, the authors obtained data with the Longitudinal Interval Follow-Up Evaluation on weekly BDD symptom status and treatment received over 1 year for 183 broadly ascertained subjects. Probabilities of full remission, partial remission, and relapse during this year were examined. Full remission was defined as minimal or no BDD symptoms and partial remission, as meeting less than full DSM-IV criteria for at least 8 consecutive weeks. Relapse was defined as meeting full BDD criteria for at least 2 consecutive weeks after attaining partial or full remission from BDD.
RESULTS: Over 1 year, the probability of full remission from BDD was only 0.09, and the probability of partial remission was 0.21. Although 84.2% of the subjects received mental health treatment during the 1-year period, mean BDD severity scores during the year reflected full DSM-IV criteria for BDD, and the mean proportion of time that the subjects met full BDD criteria was 80%. Gender and ethnicity did not significantly predict remission from BDD. Among the subjects whose BDD symptoms partially or fully remitted, the probability of relapse was 0.15.
CONCLUSIONS: These findings indicate that BDD tends to be chronic. Remission probabilities were lower than reported for mood disorders, most anxiety disorders, and personality disorders in studies with similar methods.

Entities:  

Mesh:

Year:  2006        PMID: 16648334      PMCID: PMC1613833          DOI: 10.1176/ajp.2006.163.5.907

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

1.  Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.

Authors:  Katharine A Phillips
Journal:  CNS Spectr       Date:  2002-06       Impact factor: 3.790

2.  Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard; Christina Fay; Risa Weisberg
Journal:  Psychosomatics       Date:  2005 Jul-Aug       Impact factor: 2.386

3.  Quality of life for patients with body dysmorphic disorder.

Authors:  K A Phillips
Journal:  J Nerv Ment Dis       Date:  2000-03       Impact factor: 2.254

4.  Prevalence of body dysmorphic disorder in a community sample of women.

Authors:  M W Otto; S Wilhelm; L S Cohen; B L Harlow
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

5.  A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ralph S Albertini; Steven A Rasmussen
Journal:  Arch Gen Psychiatry       Date:  2002-04

6.  Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders.

Authors:  M G Warshaw; M B Keller; R L Stout
Journal:  J Psychiatr Res       Date:  1994 Nov-Dec       Impact factor: 4.791

7.  Stability as a distinction between Axis I and Axis II disorders.

Authors:  M Tracie Shea; Shirley Yen
Journal:  J Pers Disord       Date:  2003-10

8.  Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.

Authors:  Kimberly A Yonkers; Steven E Bruce; Ingrid R Dyck; Martin B Keller
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

9.  Importance of psychotic features to long-term course in major depressive disorder.

Authors:  W Coryell; A Leon; G Winokur; J Endicott; M Keller; H Akiskal; D Solomon
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  24 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Cued panic attacks in body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard; Andri S Bjornsson
Journal:  J Psychiatr Pract       Date:  2013-05       Impact factor: 1.325

3.  Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.

Authors:  Katharine A Phillips; Aparna Keshaviah; Darin D Dougherty; Robert L Stout; William Menard; Sabine Wilhelm
Journal:  Am J Psychiatry       Date:  2016-04-08       Impact factor: 18.112

4.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

Review 5.  Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5.

Authors:  Katharine A Phillips; Ashley S Hart; Helen Blair Simpson; Dan J Stein
Journal:  CNS Spectr       Date:  2013-05-10       Impact factor: 3.790

6.  The clinical course of body dysmorphic disorder in the Harvard/Brown Anxiety Research Project (HARP).

Authors:  Andri S Bjornsson; Ingrid Dyck; Ethan Moitra; Robert L Stout; Risa B Weisberg; Martin B Keller; Katharine A Phillips
Journal:  J Nerv Ment Dis       Date:  2011-01       Impact factor: 2.254

Review 7.  [Body dysmorphic disorder : Anxiety about deformity].

Authors:  T Gieler; E Brähler
Journal:  Hautarzt       Date:  2016-05       Impact factor: 0.751

8.  Culturally Adapted Cognitive Behavioral Therapy for Body Dysmorphic Disorder: Case Examples.

Authors:  Hilary Weingarden; Luana Marques; Angela Fang; Nicole LeBlanc; Ulrike Buhlmann; Katharine A Phillips; Sabine Wilhelm
Journal:  Int J Cogn Ther       Date:  2011

9.  Impact of helping behaviors on the course of substance-use disorders in individuals with body dysmorphic disorder.

Authors:  Maria E Pagano; Katharine A Phillips; Robert L Stout; William Menard; Jane A Piliavin
Journal:  J Stud Alcohol Drugs       Date:  2007-03       Impact factor: 2.582

10.  Body dysmorphic disorder: treating an underrecognized disorder.

Authors:  Katharine A Phillips; Elizabeth R Didie; Jamie Feusner; Sabine Wilhelm
Journal:  Am J Psychiatry       Date:  2008-09       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.